Found 147 matching trials
Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer PHASE1 This phase I clinical trial evaluates the safety and feasibility of adminis...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor PHASE2 This is a Phase II, open-label, two strata, multicenter, prospective study ...
Show More Location
H. Lee Moffitt Cancer Center
Learn More & Join Trial
Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma PHASE1 Neuroblastoma is a malignant tumor of the sympathetic nervous system. It is...
Show More Location
Columbia Presbyterian Medical Center, Morgan Stanley Children's Hospital New York Presbyterian
Learn More & Join Trial
BEACON: A Study Evaluating the Safety and Efficacy of BEAM-101 in Patients With Severe Sickle Cell Disease PHASE1 This is an open-label, single-arm, multicenter, Phase 1/2 study evaluating ...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Learn More & Join Trial
Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-myeloablative Peripheral Blood Stem Cell Transplantation PHASE2 The purpose of this study is to extend the use of Tacrolimus and Sirolimus ...
Show More Location
Dana-Farber Cancer Institute
Learn More & Join Trial
A Phase I Trial of Myeloablative Conditioning w/ Clofarabine and HD Busulfan for Pts w/ Refractory Heme Malignancies Undergoing Allo PBSCT PHASE1 This is a phase trial to determine the maximum tolerated dose (MTD) of clof...
Show More Location
Indiana University Cancer Center
Learn More & Join Trial
Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies PHASE1 The goal of this clinical research study is to learn if it is safe and feas...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Feasibility and Efficacy Study of Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) With Fludarabine, Busulfan, and Total Body Irradiation (TBI) PHASE2 The purpose of this study is to evaluate the OS, RFS, and TRM after HCT wit...
Show More Learn More & Join Trial
Personalized NK Cell Therapy in CBT PHASE2 This phase II clinical trial studies how well personalized natural killer (...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Allogeneic Transplant in HIV Patients (BMT CTN 0903) PHASE2 The rationale for this trial is to demonstrate the feasibility and safety o...
Show More Location
Mayo Clinic - Phoenix
Learn More & Join Trial